Burning Rock Biotech (BNR) Other Non-Current Assets (2019 - 2026)

Burning Rock Biotech's Other Non-Current Assets history runs 8 years deep, the most recent figure standing at $1.1 million for Q1 2026.

• In Q1 2026, Other Non-Current Assets rose 2.23% year-over-year to $1.1 million; the TTM figure through Mar 2026 stood at $1.1 million (up 2.23% YoY), while the FY2025 annual figure was $1.1 million, changed 0.46% from the prior year.
• Other Non-Current Assets for Q1 2026 stood at $1.1 million, up from $1.1 million in the prior quarter.
• The five-year high for Other Non-Current Assets was $3.6 million in Q1 2022, with the low at $500000.0 in Q1 2024.
• The 5-year median for Other Non-Current Assets is $1.4 million (2024), against an average of $1.6 million.
• The sharpest annual moves came in 2023 and 2025: Other Non-Current Assets plunged 75.94% in 2023, then surged 115.6% in 2025.
• Burning Rock Biotech's Other Non-Current Assets stood at $2.9 million in 2022, then tumbled by 75.94% to $706659.1 in 2023, then soared by 56.15% to $1.1 million in 2024, then dropped by 2.48% to $1.1 million in 2025, then climbed by 2.41% to $1.1 million in 2026.
• Business Quant data shows BNR's Other Non-Current Assets at $1.1 million in Q1 2026, $1.1 million in Q4 2025, and $912000.0 in Q3 2025.